| INTRODUC TI ON
Progressive respiratory failure is the leading cause of morbidity and mortality in CF. 1 The CF population is prone to chronic airway colonisation and infection by a variety of bacterial and fungal microorganisms.
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Aspergillus fumigatus, Exophiala dermatitidis and Scedosporium apiospermum are the most prevalent clinically significant fungal species in CF patients. 5 Less frequently, Paecilomyces variotii and some
Summary
Infections caused by Rasamsonia argillacea complex have been reported in various clinical settings. Cystic fibrosis (CF) is one of the main underlying conditions. An observational cohort study of CF patients with Rasamsonia in respiratory samples was conducted. Eight isolates from 6 patients were identified as R. argillacea complex and tested for antifungal susceptibility. All isolates had high MICs to voriconazole and posaconazole and low MECs to echinocandins. Four patients experienced lung function decline in the year preceding first Rasamsonia isolation. This continued in the year following first isolation in 3 out of 4 cases. Antifungal therapy was initiated in 2 patients, to which only one exhibited a clinical response. Three out of 6 patients died within 3 years of isolating Rasamsonia. Genotyping suggests that similar genotypes of Rasamsonia can persist in CF airways. Consistent with other fungi in CF, the clinical impact of airway colonisation by Rasamsonia is variable. In certain patients, Rasamsonia may be able to drive clinical decline. In others, though a clear impact on lung function may be difficult to determine, the appearance of Rasamsonia acts as a marker of disease severity. In others it does not appear to have an obvious clinical impact on disease progression.
K E Y W O R D S
antifungal susceptibility testing, cystic fibrosis, genotyping, outcome, Rasamsonia argillacea species complex species belonging to the genus Alternaria, Cladosporium, Penicillium and Talaromyces species are cultured. 6 Prevalence rates vary considerably from one centre to another, which may be due to differences in the methods used in the recovery and identification of fungi, as well as to true differences in the geographical prevalence of species, local environmental factors and population differences in genetic susceptibility. 7 Recent studies using fungal-selective culture media and molecular techniques have revealed a higher than previously recognised prevalence and a greater diversity of fungal species in sputum samples from CF patients.
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Rasamsonia argillacea (previously Geosmithia argillacea) belongs to the emerging, thermotolerant polyphyletic Eurotiales (family Trichocomacea) and is a causative agent of invasive mycosis in patients with chronic granulomatous disease (CGD) 11 and graft-versus-host disease. 12 Pulmonary and aortic valve infection in an immunocompetent patient has been described. 13 In addition, this emerging fungal pathogen has been found to colonise CF airways. [14] [15] [16] 
| PATIENTS AND ME THODS

| Patients and sputum cultures
Sputum samples are routinely collected at every follow-up clinic appointment (i.e. 2-3 monthly) and at times of clinical exacerbation.
Respiratory samples were first treated with a mucolytic agent and then cultured onto Sabouraud dextrose agar supplemented with 100 mg/L chloramphenicol (Oxoid, Basingstoke, UK). Fungal cultures were incubated at 30°C for up to 4 weeks. Any fungal isolate was primarily identified using macroscopic features and microscopic characteristics.
Demographic and clinical characteristics and data relating to treatments received and clinical outcomes for each patient were collected through case note review. Lung function data were collected from medical records at outpatient clinic appointments.
| Fungal isolates
In total, 32 positive respiratory cultures were obtained from 6 CF patients. As not all recovered isolates were preserved, only 8 The Netherland (n = 16) was determined using amplified fragment length polymorphism (AFLP) fingerprint analysis as described by
Zhang et al, however, the 3′-side overhang "TGAC" of the selective HpyCH4IV-primer was replaced with "TGAG". 21 Raw data were imported into BioNumerics v7.6.1 (Applied Maths NV, SintMartens-Latem, Belgium) and an Amplified fragment length polymorphism (AFLP) banding patterns dendrogram with % similarity bar was generated using the ranked Pearson similarity coefficient and UPGMA clustering.
| Antifungal susceptibility and in vitro combination testing
Antifungal susceptibility testing was performed by means of broth microdilution, according to the Clinical and Laboratory Standards
Institute (CLSI) M38-A2 method for filamentous fungi. 22 The MIC was defined as the lowest concentration to inhibit 100% of growth on visual inspection for amphotericin B, itraconazole, posaconazole and voriconazole and to reduce growth by 80% for terbinafine and flucytosine compared to the drug-free control well. The minimal effective concentration (MEC) was defined as the lowest concentration seen to produce short, stubby, abnormally branched hyphae for the echinocandins. Both the MIC and the MEC were determined at 48 hours.
A checqerboard microdilution method was used for in vitro combination testing with itraconazole-micafungin and terbinafinemicafungin as previously described. 23 To ascertain the reproducibility of MIC and MEC results of combination testing, each isolate was tested in duplicate. In vitro interactions were calculated on the basis of the fractional inhibitory concentration (FIC) index, depending on whether the antifungal activity of the combination was greater than, equivalent to, or less than the activities of the individual agents respectively. The summation (ΣFIC) was interpreted as synergistic if the FICI was ≤0.5, no interaction if the FICI was >0.5-4, and antagonistic if the FICI was >4.
| Nucleotide sequence accession numbers
The nucleotide sequences obtained in this work were submitted to
GenBank under accession numbers KY649324 to KY649331.
| RE SULTS
Six CF patients with ≥1 sputum culture-positive (mean 5 isolates where Rasamsonia spp. was isolated, 8 isolates from 6 patients were available for inclusion in this study.
| Morphological characteristics
Colonies on MEA were relatively slow growing, slightly floccose with cream-buff to pale brown colour. All isolates produced colonies reaching a diameter of ~30-35 mm in 7-10 day cultures at 28-30°C with an exception of Ras_RBH_7 which demonstrated a restricted growth of ~15-17 mm ( Figure S1 ). All isolates were thermophilic, displaying good growth at 37 and 42°C. Microscopic examination of the cultures revealed hyaline, septate hyphae with conidiophores bearing monoverticillate, biverticillate or terverticillate penicilli. Rough phialides were cylindrical with a tapering tip producing smooth-walled cylindrical or ovoid conidia. Based on colonial characteristics and microscopic features all 8 isolates were identified as R. argilacea sensu lato.
| Molecular identification and phylogenetic analysis
Concatenated ITS1 and β-tubulin sequences (8 isolates from this study plus 55 additional isolates from The Netherlands including type strains) were included for molecular investigations. Phylogenetic analysis demonstrates that ITS1 and partial β-tubulin gene sequences can adequately distinguish species within the Rasamsonia genus ( Figure 1 ). The analysis also shows that isolates in the R. eburnea and R. piperina species are highly related to each other, which is suggestive of a high degree of clonality and asexual reproduction.
Two isolates Ras_RBH_2 and Ras_RBH_6, were identified as R. argillacea sensu stricto, Ras_RBH_7 was identified as R. piperina, and 5 remaining isolates were identified as R. aegroticola. UPGMA analysis grouped the isolates into 3 clusters; R. aegroticola (n = 14), R. argillacea (n = 5) and R. piperina (n = 5) (Figure 1 ). AFLP fingerprint analysis confirming the ITS1 and β-tubulin combined identifications, and the phylogenetic placement of 5 isolates (Ras_RBH_1, Ras_RBH_2, Ras_ RBH_3, Ras_RBH_6 and Ras_RBH_7). Phylogenetic analysis does not corroborate the AFLP identification of Ras_RBH_4, Ras_RBH_5
and Ras_RBH_8. Of note, AFLP fingerprint analysis clearly confirmed that 2 sets of sequential isolates Ras_RBH_1 and Ras_RBH_3 isolated 4 months apart from case 1 and Ras_RBH_2 and Ras_RBH_6 isolated 11 months apart from case 2 were highly similar ( Figure 2 ).
| Antifungal susceptibility and combination testing
The results of the antifungal susceptibility testing are summarised in Table 1 (Table S1 ), all 8 isolates demonstrated no interaction for both drug combinations.
| Clinical characteristics and infection episodes
The patients had an age range of 11-53 years (median 30.5) at first isolation of R. argillacea complex. The most common CF-related mutation was F508del, present in 5 out of 6 patients of whom 3 were homozygous ( Table 2 ). This is similar to the prevalence of ΔF508 heterogeneity and homogeneity within the UK CF population as a whole. 24 Five out of 6 patients (83%) were pancreatic insufficient, 
| D ISCUSS I ON
The presence of R. argillacea complex has been reported in invasive infections in CGD 11, 13 to airway colonisation in patients with CF. 15, 16, [25] [26] [27] [28] Infections in bone marrow transplant recipients 12 and immunocompetent hosts 13 have also been reported.
Eight isolates from 6 patients in our CF cohort were identified as members of R. argillacea complex where R. aegroticola was the most common species, followed by R. argillacea sensu stricto and R. piperina. We compared concatenated ITS1 and β-tubulin sequences from 8 UK isolates plus a diverse collection of 55 Rasamsonia isolates from the Netherlands. The same pattern of species prevalence was recently described in a large multi-centre study of 116 isolates belonging to R. argillacea complex collected from 26 CF patients. 14 Similarly, we did not find any R. eburnea among our isolates.
Genotypic similarities observed by AFLP analysis among 2 sets of sequential isolates obtained 4 and 11 months apart, in cases 1 and 2, respectively, suggests that Rasamsonia spp. can be consistently isolated from CF airways. Unfortunately, we were not able to examine the genotypic diversity among all sequential isolates from our patients as these fungal isolates were no longer available for testing.
However, high level of similarities observed among 2 sets of our sequential isolates is in line with the results of a recent comprehensive genotyping analysis which identified the ability of R. aegroticola and R. argillacea to chronically infect the CF airway.
14 Amplified fragment length polymorphism analysis has been widely used as a genotyping and identification tool, but it was not applied before onto a set of Rasamsonia spp. isolates. With this rapid molecular genotyping method 3 major Rasamsonia clusters were observed, 2 clusters contain isolates that were by combined ITS/β-tubulin sequencing identified as a different species which may question the suitability of the former as ITS/β-tubulin sequencing has been observed to be a reliable tool for Rasamsonia species discrimination. 17 However, by applying AFLP fingerprinting a larger part of the genomic information is used when compared to ITS/β-tubulinbased identification, hence AFLP analysis gives more resolution but that does not explain that isolate Ras_RBH_8 fell by AFLP analysis in the R. piperina-cluster, whereas it was found to be R. aegroticola by sequencing as the AFLP fingerprint profile was similar to that of an isolate that was by sequencing found to be R. piperina. TA B L E 2 Summary of characteristic features of reported 6 cases of Rasamsonia species chronic colonisation in 8 CF patients may contribute to respiratory decline in cystic fibrosis, in a manner that is dependent upon the underlying severity of lung disease. This 
